We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Taking Questions on ICH Guidance for Nonclinical Evaluation of Cancer Drugs
FDA Taking Questions on ICH Guidance for Nonclinical Evaluation of Cancer Drugs
The FDA is taking public questions and comments relating to implementing a global guidance from 2010 on the nonclinical evaluation of anticancer drugs, also known as the S9 guidance, developed by the International Council for Harmonisation.